The Cost-Effectiveness of Hepatitis C Virus Screening Strategies among Recently Arrived Migrants in the Netherlands
Mohamed N.M.T. Al Khayat,
Job F.H. Eijsink,
Maarten J. Postma,
Jan C. Wilschut and
Marinus van Hulst
Additional contact information
Mohamed N.M.T. Al Khayat: Department of Health Sciences, University of Groningen, University Medical Center Groningen, 9712 CP Groningen, The Netherlands
Job F.H. Eijsink: Department of Health Sciences, University of Groningen, University Medical Center Groningen, 9712 CP Groningen, The Netherlands
Maarten J. Postma: Department of Health Sciences, University of Groningen, University Medical Center Groningen, 9712 CP Groningen, The Netherlands
Jan C. Wilschut: Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, 9712 CP Groningen, The Netherlands
Marinus van Hulst: Department of Health Sciences, University of Groningen, University Medical Center Groningen, 9712 CP Groningen, The Netherlands
IJERPH, 2020, vol. 17, issue 17, 1-13
Abstract:
Objective: We aimed to assess the cost-effectiveness of hepatitis C virus (HCV) screening strategies among recently arrived migrants in the Netherlands. Methods: A Markov model was used to estimate the health effects and costs of HCV screening from the healthcare perspective. A cohort of 50,000 recently arrived migrants was used. In this cohort, three HCV screening strategies were evaluated: (i) no screening, (ii) screening of migrants from HCV-endemic countries and (iii) screening of all migrants. Results: Strategy (ii) screening of migrants from HCV-endemic countries compared to strategy (i) no screening, yielded an incremental cost-effectiveness ratio (ICER) of €971 per quality-adjusted life-years (QALYs) gained. Strategy (iii) screening of all migrants compared with strategy (ii) screening of migrants from HCV-endemic countries yielded an ICER of €1005 per QALY gained. The budget impact of strategy (ii) screening of migrants from HCV-endemic countries and strategy (iii) screening of all migrants was €13,752,039 and €20,786,683, respectively. Conclusion: HCV screening is cost-effective. However, the budget impact may have a strong influence on decision making.
Keywords: hepatitis C; screening; migrants; cost-effectiveness; budget impact (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://www.mdpi.com/1660-4601/17/17/6091/pdf (application/pdf)
https://www.mdpi.com/1660-4601/17/17/6091/ (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:17:y:2020:i:17:p:6091-:d:402220
Access Statistics for this article
IJERPH is currently edited by Ms. Jenna Liu
More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().